BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23506899)

  • 1. Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.
    Motohashi H; Inui K
    Mol Aspects Med; 2013; 34(2-3):661-8. PubMed ID: 23506899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of the multidrug and toxin extrusion MATE/SLC47A family to pharmacokinetics, pharmacodynamics/toxicodynamics and pharmacogenomics.
    Yonezawa A; Inui K
    Br J Pharmacol; 2011 Dec; 164(7):1817-25. PubMed ID: 21457222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
    Motohashi H; Nakao Y; Masuda S; Katsura T; Kamba T; Ogawa O; Inui K
    J Pharm Sci; 2013 Sep; 102(9):3302-8. PubMed ID: 23630107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular identification and functional characterization of rabbit MATE1 and MATE2-K.
    Zhang X; Cherrington NJ; Wright SH
    Am J Physiol Renal Physiol; 2007 Jul; 293(1):F360-70. PubMed ID: 17442726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal tubular secretion of varenicline by multidrug and toxin extrusion (MATE) transporters.
    Kajiwara M; Masuda S; Watanabe S; Terada T; Katsura T; Inui K
    Drug Metab Pharmacokinet; 2012; 27(6):563-9. PubMed ID: 22510868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).
    Saad AAA; Zhang F; Mohammed EAH; Wu X
    Biol Pharm Bull; 2022; 45(4):382-393. PubMed ID: 35370262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of human multidrug and toxin extrusion 1 (MATE1) transporter with antineoplastic agents.
    Grottker J; Rosenberger A; Burckhardt G; Hagos Y
    Drug Metabol Drug Interact; 2011; 26(4):181-9. PubMed ID: 22149660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.
    Motohashi H; Inui K
    AAPS J; 2013 Apr; 15(2):581-8. PubMed ID: 23435786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity.
    Kajiwara M; Terada T; Ogasawara K; Iwano J; Katsura T; Fukatsu A; Doi T; Inui K
    J Hum Genet; 2009 Jan; 54(1):40-6. PubMed ID: 19158817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A).
    Terada T; Inui K
    Biochem Pharmacol; 2008 May; 75(9):1689-96. PubMed ID: 18262170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug and toxin extrusion proteins (MATE/SLC47); role in pharmacokinetics.
    Staud F; Cerveny L; Ahmadimoghaddam D; Ceckova M
    Int J Biochem Cell Biol; 2013 Sep; 45(9):2007-11. PubMed ID: 23831838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
    van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
    Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human multidrug and toxin extrusion 1 (MATE1/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms.
    Meyer zu Schwabedissen HE; Verstuyft C; Kroemer HK; Becquemont L; Kim RB
    Am J Physiol Renal Physiol; 2010 Apr; 298(4):F997-F1005. PubMed ID: 20053795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-methylnicotinamide is an endogenous probe for evaluation of drug-drug interactions involving multidrug and toxin extrusions (MATE1 and MATE2-K).
    Ito S; Kusuhara H; Kumagai Y; Moriyama Y; Inoue K; Kondo T; Nakayama H; Horita S; Tanabe K; Yuasa H; Sugiyama Y
    Clin Pharmacol Ther; 2012 Nov; 92(5):635-41. PubMed ID: 23047651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters.
    Tanihara Y; Masuda S; Sato T; Katsura T; Ogawa O; Inui K
    Biochem Pharmacol; 2007 Jul; 74(2):359-71. PubMed ID: 17509534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
    Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF
    Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ondansetron can enhance cisplatin-induced nephrotoxicity via inhibition of multiple toxin and extrusion proteins (MATEs).
    Li Q; Guo D; Dong Z; Zhang W; Zhang L; Huang SM; Polli JE; Shu Y
    Toxicol Appl Pharmacol; 2013 Nov; 273(1):100-9. PubMed ID: 24001450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue distribution, ontogeny and induction of the transporters Multidrug and toxin extrusion (MATE) 1 and MATE2 mRNA expression levels in mice.
    Lickteig AJ; Cheng X; Augustine LM; Klaassen CD; Cherrington NJ
    Life Sci; 2008 Jul; 83(1-2):59-64. PubMed ID: 18573474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.